Sweta Shah
About
In The Last Decade
Sweta Shah
22 papers receiving 250 citations
Peers
Comparison fields: 5 of 65
- Molecular Biology 96
- Oncology 84
- Infectious Diseases 55
- Epidemiology 47
- Molecular Medicine 45
Countries citing papers authored by Sweta Shah
This map shows the geographic impact of Sweta Shah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sweta Shah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sweta Shah more than expected).
Fields of papers citing papers by Sweta Shah
This network shows the impact of papers produced by Sweta Shah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sweta Shah. The network helps show where Sweta Shah may publish in the future.
Co-authorship network of co-authors of Sweta Shah
This figure shows the co-authorship network connecting the top 25 collaborators of Sweta Shah. A scholar is included among the top collaborators of Sweta Shah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sweta Shah. Sweta Shah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 1 | |
| 5 | 2 | |
| 6 | 28 | |
| 7 | 2 | |
| 8 | 5 | |
| 9 | 5 | |
| 10 | 9 | |
| 11 | 12 | |
| 12 | 11 | |
| 13 | 18 | |
| 14 | 10 | |
| 15 | 5 | |
| 16 | 15 | |
| 17 | COLISTIN-CARBAPENEM COMBINATION THERAPY AGAINST CARBAPENEM RESISTANT GRAM NEGATIVE BACILLI INFECTIONS: CLINICAL AND AN IN VITRO SYNERGY STUDY | 5 |
| 18 | 3 | |
| 19 | 2 | |
| 20 | 117 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.